Codexis to Participate in Cantor Global Healthcare
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company...
Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company...
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare Conference, being held
Benchmark restated their buy rating on shares of Codexis (NASDAQ:CDXS – Free Report) in a research note released on Friday, Benzinga reports. Benchmark currently has a $9.00 price objective on the biotechnology company’s stock. CDXS has been the subject of several other reports. HC Wainwright cut Codexis from a buy rating to a neutral rating […]
/PRNewswire/ -- The "Ligase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Product, By Source, By...
Wilmington, Delaware, United States, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for enzymes was estimated to be worth US$ 7.7 billion in 2021. The market is anticipated to